KATRINA PAULSON: Open Payments
NPI 1124199724 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 14 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $433 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $238 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $32 |
| Novo Nordisk Inc | 1 | $21 |
| Boston Scientific Corporation | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, LEQVIO, Veozah, FARXIGA, EVENITY, Wegovy, WATCHMAN FLX, Ohtuvayre.
Industry payments across MT — which companies pay providers there.
